Cannabis Science Inc
.jpg) |
Technical Analysis
Cannabis Science Inc has been moving in bearish trend start of the year 2015.CBIS’s stock is moving in a series of crest and through trending downwards However the stock did saw a major bullish rally in the months of January, 2015 when its touched its high of $0.08 at a trading volume of 20.31 million.
The
share price highest and lowest for the period of 52-weeks is $0.21 and $0.03 respectively.
The stock maintains good liquidity with average volume of around 8 million
shares per day as compared to the 5.2 million shares traded on average represented
a sizable increase in volume.
Promotional
Analysis
Cannabis Science Inc is busy in releasing PR statements stating old stuff that the product line is in pipe line and soon they will launch their products throughout the markets in California but the products are nowhere. CBIS just want to create hype in the investors through its Golden statements about its future and its business plans but infect it is involved in heavy stock dumping in open market.
About
Us
Cannabis Science Inc is a medical marijuana research and development company. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. It is focused on developing cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company has two subsidiaries: The Company formed two operating subsidiaries Cannabis Science BV and Cannabis Science International Holding BV. The Company has partnered with propagators and laboratories for extractions, analytical development and clinical trial implementation. It uses an inquiring approach to discover and develop cannabinoid-based therapies.
Recent News
Cannabis
Science Inc Raymond C. Dabney was appointed as the Vice Chair of
the newly launched Constituency for Africa (CFA) Africa Healthcare
Infrastructure Committee.The committee held its inaugural meeting on February
5, 2015 at the African Union Mission to discuss its charge from CFA President,
Mr. Melvin Foote, and to approve a conceptual framework program of work.
Building on the successful model by CFA of using Town Hall formats and
commissioning lectures to highlight priorities, The Committee discussed to hold
the Africa Healthcare Infrastructure Forum & Brainstorm Session on February
6 at the African Union Mission in terms of the expected outcome and to
establish the five standing sub-committees on EDUCATION, AGRICULTURE, FOOD
SECURITY, TECHNOLOGY & COMMUNICATION, LEADERSHIP, POLITICAL ENGAGEMENT
& POLICY, and HEALTHCARE INFRASTRUCTURE to develop and sustain programs in
these areas.
Conclusion
Cannabis
Science Inc fundamentals look quite disastrous, being a
development stage company having $0.44 million in cash and total assets of
$1.00.the total liabilities of the company stands on $4.16 million resulting in
negative equity despite of the fact that Additional capital injected during the year was $99.35 million.
The Company does not have enough going to
support anywhere near current valuations, let alone the several $100 M valuation
it was trading at the hype of marijuana news height. As of the last filling, CBIS
has not generated even $1 revenues to date since there quarterly filings.
Considering the fundamentals
its market capitalization of $46.75 million is clearly overstated.
